The prices and affordability of recently developed and highly effective direct-acting antivirals for treating hepatitis C vary greatly among countries worldwide, according to a new study.
This full article appears on <a href="https://www.sciencedaily.com/releases/2016/05/160531165229.htm">Science Daily</a>